Background: Alzheimer's disease (AD), the most common cause of dementia in adulthood,
has great medical, social, and economic impact worldwide. Available treatments result in …

Alzheimer's disease (AD) is the leading cause of dementia; however, men and women face
differential AD prevalence, presentation, and progression risks. Characterizing metabolomic …

Metabolomics in the Alzheimer's Disease Neuroimaging Initiative cohort provides a powerful
tool for mapping biochemical changes in Alzheimer's disease, and a unique opportunity to …

We recently reported that alpha-2 macroglobulin (A2M) is a biomarker of neuronal injury in
Alzheimer's disease (AD) and identified a network of nine genes co-expressed with A2M in …

Alzheimer's disease (AD) is the most common cause of dementia. The mechanism of
disease development and progression is not well understood, but increasing evidence …

Recent reports have shown that apolipoprotein E (APOE) polymorphisms are involved in
neurodegenerative disease. However, it is unclear whether APOE affects post-stroke …

There is evidence of correlation between mild cognitive impairment (MCI) and sarcopenia
(SA). However, the influencing factors and the mechanism, such as age-related lipid …

不同运动方式对大脑结构及认知功能的调节作用及差异 Page 1 3252 |中国组织工程研究|第25卷
|第20期|2021年7月 不同运动方式对大脑结构及认知功能的调节作用及差异 路毅,邓文冲 文题释义 …

Phosphatidylcholine (PC) is an essential part of human cell membranes and an important
dietary source of choline, an important biochemical. Its common name is lecithin. It can be …

Alzheimer's disease (AD) is associated with metabolic abnormalities linked to critical
elements of neurodegeneration. Here, we analysed the brain transcriptomics data of more …